• Diagnosis​ Info ​and​ ​General​ ​Questions

  FDA Approves 1st Sickle Cell Treatment, Oxbryta, Targeting Root Cause of Disease

  Posted by Sickle Cell Forum Administrator on March 5, 2021 at 9:00 am

  1. 

  The FDA has given accelerated approved to oral Oxbryta (voxelotor), a once-daily treatment targeting sickle cell’s root cause, for patients ages 12 and up. Click here to read more.

  What do you think of this news?

  Sickle Cell Forum Administrator replied 4 years, 3 months ago 0 Member · 0 Replies

  • FDA
  • Treatment
• 0 Replies

Log In to Reply